Optimal chemotherapy for high-risk early-stage breast cancer
- PMID: 20406917
- DOI: 10.1200/JCO.2010.28.1196
Optimal chemotherapy for high-risk early-stage breast cancer
Comment on
-
Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer.J Clin Oncol. 2010 Jan 1;28(1):77-82. doi: 10.1200/JCO.2009.22.1077. Epub 2009 Nov 9. J Clin Oncol. 2010. PMID: 19901117 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
